SCHEMBL5325302

SCHEMBL5325302

NC(CCc1ccc2scccc1-2)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 4/20 0.41
CYP2C19 P33261 1/20 0.37
LTA4H P09960 1/20 0.37
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
ALPI P09923 1/20 0.36
PKM P14618 1/20 0.36
PTGS1 P23219 1/20 0.36
XIAP P98170 1/20 0.36
SLC7A5 Q01650 1/20 0.36
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
GRIK1 P39086 1/20 0.35
GRIA1 P42261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5327692 0.85 PKM (0.45) KIF11CYP2C19LTA4HSLC1A3SLC1A2
SCHEMBL5319858 0.77 TP53 (0.40) KIF11CYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL9584558 0.75 CYP2C19 (0.56) KIF11CYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL7275819 0.75 CYP2C19 (0.56) KIF11CYP2C19SLC1A3SLC1A2SLC1A1
SCHEMBL9450326 0.73 ALDH1A1 (0.44) LTA4HKDM4EALDH1A1GAAMAPT
SCHEMBL5322027 0.71 SLC1A3 (0.40) KIF11SLC1A3SLC1A2SLC1A1MAPT
SCHEMBL5324715 0.71 SLC1A3 (0.40) KIF11SLC1A3SLC1A2SLC1A1GRIK1
SCHEMBL9449867 0.69 LTA4H (0.42) LTA4HKDM4EALDH1A1GAAMAPT
SCHEMBL5539652 0.69 LTA4H (0.53) LTA4HKDM4EALDH1A1GAAMAPT
SCHEMBL27133166 0.69 LTA4H (0.47) LTA4HKDM4EALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070258899-A1 Diagnostic and therapeutic agents KARYON-CTT LTD (FI) 2007-11-08 US disclosed
WO-2007113385-A1 DIAGNOSTIC AND THERAPEUTIC AGENTS KARYON-CTT LTD (FI) 2007-10-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258899-A1 Diagnostic and therapeutic agents YBX1, MLX, TPX2 KIF11 1678/4885CYP2C19 4437/4885LTA4H 4133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.